Soquelitinib
CPI-818-003
Phase 2 small_molecule active
Quick answer
Soquelitinib for Atopic Dermatitis is a Phase 2 program (small_molecule) at Corvus Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Corvus Pharmaceuticals
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active